Cofactor Genomics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 19
Employees
  • Latest Deal Type
  • Series AA
  • Latest Deal Amount
  • $2.5M
Latest Deal Amount
  • Investors
  • 24

Cofactor Genomics General Information

Description

Developer of a biotechnology platform intended help in RNA sequencing and expression analysis. The company's platform examines RNA biomarkers known to be associated with response to targeted therapeutics, enabling biotech companies to commercialize a suite of clinical diagnostic assays targeting oncologic, immunologic and neurodegenerative diseases

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Database Software
Primary Office
  • 300 Brannan Street
  • Suite 410
  • San Francisco, CA 94107
  • United States
+1 (888) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cofactor Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series AA) 22-Dec-2020 $2.5M 000.00 Completed Generating Revenue
4. Accelerator/Incubator 000.00 Completed Generating Revenue
3. Later Stage VC (Series A) 14-Jun-2017 0000 000.00 000.00 Completed Generating Revenue
2. Accelerator/Incubator 18-Aug-2015 $120K $120K 00.000 Completed Generating Revenue
1. Grant 21-Jul-2015 $1.66M Completed Generating Revenue
To view Cofactor Genomics’s complete valuation and funding history, request access »

Cofactor Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4 000,000 00.000000 00.0 00.00 00.00 00 00.00 0.000
Series A-3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-2 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-1 137,988 $0.000010 $0.06 $0.72 $0.72 1x $0.72 0.7%
Series A 5,692,167 $0.000010 $0.18 $2.2 $2.2 1x $2.2 28.82%
To view Cofactor Genomics’s complete cap table history, request access »

Cofactor Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biotechnology platform intended help in RNA sequencing and expression analysis. The company's platform ex
Biotechnology
San Francisco, CA
19 As of 2021
000.00
00000000000 000.00

00000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
0000 000000000
Menlo Park, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

te irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exce
0000 000000000
Pune, India
00 As of 0000
000000 - 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cofactor Genomics Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Personalis Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
000000000 Formerly VC-backed Pune, India 00 000000 - 000
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 000000&0
000000 Formerly VC-backed Vista, CA 000 00000 00000000 00000
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
You’re viewing 5 of 10 competitors. Get the full list »

Cofactor Genomics Executive Team (5)

Name Title Board Seat Contact Info
Jarret Glasscock Ph.D Co-Founder, Chief Executive Officer & Board Member
David Messina Ph.D Co-Founder & Chief Operating Officer
Cheryl Morley Advisor
Rob Goltermann Member of the Advisory Board
Jon Armstrong Chief Scientific Officer
To view Cofactor Genomics’s complete executive team members history, request access »

Cofactor Genomics Board Members (5)

Name Representing Role Since
Jarret Glasscock Ph.D Cofactor Genomics Co-Founder, Chief Executive Officer & Board Member 000 0000
John Kuelper JD Ascension Ventures Board Member 000 0000
Mark Siegel Menlo Ventures Board Member 000 0000
Matthew Ocko DCVC Board Member 000 0000
William Hagstrom Self Board Member 000 0000
To view Cofactor Genomics’s complete board members history, request access »

Cofactor Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cofactor Genomics Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fifty Years Venture Capital Minority 000 0000 000000 0
Lagomaj Capital Venture Capital Minority 000 0000 000000 0
7percent Ventures Venture Capital Minority 000 0000 000000 0
AME Cloud Ventures Venture Capital Minority 000 0000 000000 0
Argonautic Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 24 investors. Get the full list »

Cofactor Genomics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 02-Feb-2016 000000000000000000 Biotechnology 000000 000000000 00.0
To view Cofactor Genomics’s complete acquisitions history, request access »